Table 9.
Interaction | Treatments | Glucose | Triglyceride | Total cholesterol | High-density cholesterol | Low-density cholesterol | Total proteins | Albumin | Globulin | Albumin/Globulin |
---|---|---|---|---|---|---|---|---|---|---|
Day 17 | Control | 11.23a,b | 1.21d | 19.64b | 2.09b,c | 1.26a | 19.64b | 11.20c | 11.62b | 0.97b,c |
CP | 9.01c | 1.23d | 19.92b | 2.00c | 1.22a,b | 19.92b | 11.96b,c | 12.04b | 0.99b,c | |
CA | 11.20a,b | 1.28d | 19.70b | 2.14b,c | 1.23a,b | 19.70b | 11.64b,c | 11.76b | 0.99b,c | |
CA + CP | 10.35b | 1.25d | 19.91b | 2.11b,c | 1.22a,b | 19.91b | 12.24b | 12.00b | 1.02a,b | |
AB | 11.01a,b | 1.23d | 19.54b | 2.20b | 1.28a | 19.54b | 11.52c | 12.04b | 0.96b,c | |
AB + CP | 9.32c | 1.09e | 17.36c | 1.87c | 1.09b | 17.36c | 10.46d | 10.46c | 0.88c | |
Day 21 | Control | 11.24a,b | 2.13b | 20.44a,b | 2.43a | 1.23a,b | 20.44a,b | 12.66a,b | 12.62a,b | 1.00b |
CP | 8.03d | 1.78c | 19.98b | 2.49a | 1.26a | 19.98a,b | 13.10a | 12.08b | 1.09a | |
CA | 10.54b | 2.25a | 20.40a,b | 2.52a | 1.23a,b | 20.40a,b | 12.72a,b | 12.40a,b | 1.03a,b | |
CA + CP | 11.41a | 2.19a,b | 20.58a | 2.44a | 1.24a,b | 20.58a | 12.96a | 12.78a | 1.02a,b | |
AB | 10.77b | 2.17a,b | 20.02a,b | 2.48a | 1.27a | 20.02a,b | 12.66a,b | 12.10b | 1.05a,b | |
AB + CP | 9.29c | 1.85c | 17.83c | 2.17b | 1.10b | 17.83c | 11.29c | 10.98c | 0.91c | |
SEM | 0.205 | 0.030 | 0.208 | 0.049 | 0.027 | 0.227 | 0.245 | 0.189 | 0.029 | |
Stage | ||||||||||
Day 17 | 10.35 | 1.22b | 19.34b | 2.07b | 1.22 | 19.34b | 11.50b | 11.65b | 0.97b | |
Day 21 | 10.21 | 2.06a | 19.88a | 2.42a | 1.22 | 19.88a | 12.56a | 12.16a | 1.02a | |
SEM | 0.084 | 0.012 | 0.085 | 0.020 | 0.011 | 0.093 | 0.100 | 0.077 | 0.012 | |
Treatments | ||||||||||
Control | 11.24a | 1.67b | 20.04a,b | 2.26a | 1.24a | 20.04a,b | 11.93b | 12.12a | 0.98a | |
CP | 8.52c | 1.50c | 19.95a,b | 2.24a | 1.24a | 19.95a,b | 12.53a,b | 12.06a | 1.04a | |
CA | 10.87a | 1.76a | 20.05a,b | 2.33a | 1.23a | 20.05a,b | 12.18a,b | 12.08a | 1.01a | |
CA + CP | 10.88a | 1.72a,b | 20.24a | 2.28a | 1.23a | 20.24a | 12.60a | 12.39a | 1.02a | |
AB | 10.89a | 1.70b | 19.78b | 2.34a | 1.28a | 19.78b | 12.09b | 12.07a | 1.00a | |
AB + CP | 9.30b | 1.47c | 17.60c | 2.02b | 1.10b | 17.60c | 10.88c | 10.72b | 0.90b | |
SEM | 0.145 | 0.021 | 0.147 | 0.035 | 0.019 | 0.160 | 0.173 | 0.133 | 0.020 | |
P-values | ||||||||||
Stage | 0.245 | <0.001 | <0.001 | <0.001 | 0.747 | <0.001 | <0.001 | <0.001 | 0.006 | |
Treatments | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
Stage × Treatments | <0.001 | <0.001 | 0.555 | 0.345 | 0.835 | 0.643 | 0.724 | 0.086 | 0.494 |
In the same line, the same letter superscripts mean no significant difference (P > 0.05), and the different letter superscripts mean significant difference (P < 0.05).
Abbreviations: AB, antibiotic group; AB + CP, antibiotic + C. perfringens group; CA, chlorogenic acid group; CA + CP, chlorogenic acid + C. perfringens group; CP, C. perfringens group; SPF, specific-pathogen-free.